The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer

Keyphrases

• Oropharyngeal Squamous Cell Carcinoma (OPSCC) 100%
• Non-recurrent 100%
• Mutational Landscape 100%
• Human Papillomavirus-related Oropharyngeal Cancer 100%
• Human Papillomavirus 52%
• Recurring 41%
• Head-and-neck Cancer 23%
• Metachronous 23%
• Genomic Landscape 23%
• Cancer Research 11%
• HPV-negative 11%
• Otolaryngology 5%
• Response Rate 5%
• Genetic Modification 5%
• Copy number Variation 5%
• Signaling Pathway 5%
• Whole Exome Sequencing 5%
• Tumor Protein p53 (TP53) 5%
• Laboratory Research 5%
• JAK-STAT 5%
• Platinum-based 5%
• Tumor Research 5%
• HLA-A 5%
• American Cancer Society 5%
• Seattle 5%
• FAT1 5%
• Oral Tongue Squamous Cell Carcinoma (OTSCC) 5%
• Aberrations 5%
• Department of Veterans Affairs 5%
• NFE2L2 5%
• Genomic Difference 5%
• Chemoradiotherapy 5%
• Pittsburgh 5%
• Excellent Response 5%
• Tuberous Sclerosis Complex 5%
• Significantly mutated Genes 5%
• Functional Experiments 5%
• Genomic Features 5%
• CASP8 5%
• NSD1 5%
• Ajuba 5%
• Laboratory Development 5%
• BRIP1 5%
• Research Training 5%
• Funding Support 5%
• Biomedical Laboratories 5%

Biochemistry, Genetics and Molecular Biology

• Wart Virus 100%
• Genomics 70%
• Signal Transduction 10%
• Exome Sequencing 10%
• Mutated Genes 10%
• HLA-A 10%
• Mitogen-Activated Protein Kinase 10%
• TSC2 10%
• NFE2L2 10%
• NSD1 10%
• BRIP1 10%
• Nucleotide 10%

Immunology and Microbiology

• Squamous Cell 100%
• Wart Virus 100%
• Neck 23%
• Signal Transduction 5%
• Whole Exome Sequencing 5%
• Histone-Lysine N-Methyltransferase 2D 5%